Can I Take Creatine with Jatenzo?

How Jatenzo Works and Why Monitoring Matters

Jatenzo is the first FDA-approved oral testosterone product formulated as a lipophilic soft-gel capsule designed to be absorbed through the intestinal lymphatic system, bypassing first-pass hepatic metabolism. Each capsule contains testosterone undecanoate, a long-chain fatty-acid ester of testosterone. The starting dose is 158 mg twice daily with food, titrated based on serum total testosterone drawn 4 to 6 hours post-dose.

The FDA approved Jatenzo in March 2019 for adult males with primary hypogonadism or hypogonadotropic hypogonadism. Its prescribing information carries a boxed warning for blood pressure elevation: in a 180-day open-label trial, mean systolic blood pressure rose by 3.5 mmHg from baseline, with 21 percent of participants requiring new or intensified antihypertensive therapy (FDA label, Jatenzo).

Why Renal Labs Are Part of Jatenzo Follow-Up

Testosterone therapy broadly affects erythropoiesis (red blood cell production), fluid retention, and blood pressure. All three of these processes interact with renal physiology. Clinicians monitoring men on Jatenzo typically order a comprehensive metabolic panel that includes serum creatinine and estimated glomerular filtration rate (eGFR). If those numbers shift, the differential has to include both true renal injury and the more benign cause: creatine supplementation.

Jatenzo's Absorption Mechanism Is Unique Among TRT Forms

Because Jatenzo relies on chylomicron-mediated lymphatic uptake, fat content of the meal eaten at dosing time directly determines bioavailability. A low-fat meal produces measurably lower testosterone exposure. This absorption pathway is entirely separate from any pathway creatine uses, which matters when evaluating whether the two substances compete or interact at the pharmacokinetic level. They do not.

What Creatine Actually Does in the Body

Creatine monohydrate is one of the most studied ergogenic supplements in sports medicine. The human body synthesizes approximately 1 to 2 g of creatine per day from arginine, glycine, and methionine in the liver and kidneys. Dietary creatine from meat and fish supplies another 1 to 2 g per day in omnivores. Supplemental doses of 3 to 5 g per day saturate skeletal muscle phosphocreatine stores within two to four weeks without a loading phase (Kreider et al., J Int Soc Sports Nutr, 2017).

The Creatinine Problem

Here is the part that confuses many labs and some clinicians. Creatinine, the metabolic waste product used to estimate kidney filtration, is derived from the non-enzymatic degradation of both creatine and phosphocreatine. When you flood muscle tissue with exogenous creatine, total body creatine turnover rises, and so does daily creatinine production. This is not a sign of kidney damage. It is a predictable chemical consequence.

A randomized crossover trial by Poortmans and Francaux (N=18) showed that 5 g per day of creatine monohydrate for five days raised plasma creatinine by 19 percent on average without any change in urinary albumin excretion, inulin clearance, or cystatin C, all of which are more sensitive markers of true glomerular injury (Poortmans et al., Med Sci Sports Exerc, 1999). A later systematic review covering 12 controlled trials reached the same conclusion: creatine does not impair renal function in healthy individuals or those with one kidney, when taken at standard doses (Gualano et al., Amino Acids, 2012).

What "Elevated Creatinine" Means on a Lab Report

Standard reference ranges for serum creatinine in adult males run roughly 0.74 to 1.35 mg/dL. A man whose creatinine sits at 1.1 mg/dL at baseline might read 1.3 to 1.4 mg/dL after three weeks of creatine supplementation. That value sits at the upper limit of normal and could prompt a physician unfamiliar with the supplement history to order a nephrology referral, repeat labs, or even recommend stopping Jatenzo out of an abundance of caution. None of those steps are necessary if the creatine use is disclosed at the time of the draw.

Is There a Direct Interaction Between Creatine and Jatenzo?

No pharmacokinetic interaction exists between creatine and oral testosterone undecanoate. They are absorbed through different mechanisms, metabolized by different enzymes, and excreted through different pathways. Creatine is not a substrate, inhibitor, or inducer of CYP3A4, the primary enzyme involved in testosterone ester metabolism. The FDA prescribing information for Jatenzo lists insulin, corticosteroids, and anticoagulants as clinically relevant drug interactions, with no mention of creatine or other common ergogenic supplements (FDA label, Jatenzo).

The Pharmacodynamic Overlap Worth Knowing

While no direct drug interaction exists, both Jatenzo and creatine push lean mass gains and strength outputs in overlapping directions through independent mechanisms. Testosterone acts on androgen receptors to increase muscle protein synthesis and satellite cell activation. Creatine raises intramuscular phosphocreatine availability, allowing faster ATP regeneration during high-intensity efforts and slightly enhanced training volume over time. These effects are additive rather than synergistic in the chemical sense, and no published trial has identified any adverse pharmacodynamic interaction from combining them.

A 2003 double-blind trial by Crowe et al. (N=24) showed that creatine supplementation combined with resistance training produced significantly greater gains in lean mass than training alone, with no adverse hormonal or renal findings (Crowe et al., Eur J Appl Physiol, 2003). The subjects were not on TRT, but the mechanistic logic holds because testosterone's anabolic pathway and creatine's energetic pathway converge at the level of muscle protein accretion without one interfering with the other's signaling cascade.

What About Hematocrit?

Testosterone therapy raises hematocrit and hemoglobin by stimulating erythropoietin production. Jatenzo's label requires hematocrit monitoring at 3 to 6 months after initiation, then annually. Creatine has no established effect on erythropoiesis, so this monitoring parameter is unaffected by creatine use. A hematocrit above 54 percent is the standard threshold at which most clinicians pause TRT and recheck in four to six weeks.

Monitoring Recommendations When Using Both

This is where clinical management actually differs from the simple "no interaction" answer. When a man on Jatenzo also takes creatine regularly, the standard comprehensive metabolic panel becomes a less reliable tool for screening renal function.

Preferred Lab Strategy: Cystatin C Over Creatinine

Cystatin C is a low-molecular-weight protein filtered freely at the glomerulus and reabsorbed but not secreted by tubules. Its serum concentration reflects GFR independently of muscle mass and creatine turnover. A 2019 review published in the American Journal of Kidney Diseases confirmed that cystatin C-based eGFR equations outperform creatinine-based equations in individuals with altered creatine metabolism, including those with high dietary protein intake or creatine supplementation (Inker et al., Am J Kidney Dis, 2019). If your prescriber runs a cystatin C-based eGFR alongside standard creatinine, a creatine-induced creatinine elevation will not produce a false-alarm result.

Baseline Labs Before Starting Creatine

If you are already stable on Jatenzo and want to add creatine, the most practical step is to get a comprehensive metabolic panel drawn before you start the supplement. That gives your physician a creatinine baseline they can compare against future draws. Document the date creatine supplementation began in your chart.

Timing of Lab Draws

Serum creatinine rises within 3 to 7 days of starting creatine supplementation and remains elevated for as long as you continue taking it. If your scheduled Jatenzo monitoring labs fall within that window, tell the phlebotomist and your ordering clinician that you are currently taking creatine. This notation takes 10 seconds and prevents diagnostic confusion.

Blood Pressure Considerations

Jatenzo's boxed warning centers on blood pressure elevation. Creatine itself has a neutral to mildly favorable effect on blood pressure in most controlled trials. A meta-analysis of nine randomized controlled trials (total N=517) found no statistically significant change in systolic or diastolic blood pressure from creatine supplementation (Gualano et al., Amino Acids, 2012). Blood pressure monitoring on Jatenzo does not require any modification because of creatine use.

Practical Dosing and Timing Guidance

Neither Jatenzo nor creatine requires a specific separation window relative to the other. The two can be taken at the same meal without any concern about competition for absorption or metabolism.

Recommended Creatine Dose on Jatenzo

The International Society of Sports Nutrition's position stand recommends 3 to 5 g of creatine monohydrate per day as a maintenance dose, with no loading phase required if you are willing to wait three to four weeks for full muscle saturation (Kreider et al., J Int Soc Sports Nutr, 2017). Doses above 5 g per day do not produce proportionally greater muscle phosphocreatine loading and increase the daily creatinine excretion burden unnecessarily. Staying at or below 5 g per day is the practical upper limit for men on Jatenzo who want to keep lab interpretation clean.

Loading Phase Caution

Some protocols call for a loading phase of 20 g per day split into four doses for five to seven days. This approach does saturate muscles faster but produces a sharp, short-term creatinine spike that could coincide with scheduled Jatenzo monitoring labs. Skipping the loading phase and using 3 to 5 g per day from the start avoids this artifact entirely.

Food, Fat, and Jatenzo Absorption

Jatenzo must be taken with food containing fat. Creatine monohydrate dissolves readily in water and is typically taken as a powder mixed into a beverage. Taking creatine alongside the same meal you use for your Jatenzo dose is convenient and does not interfere with Jatenzo's lymphatic absorption because creatine is a hydrophilic molecule that travels via portal circulation rather than lymph.

Who Should Be More Cautious

Most men on Jatenzo can use creatine without meaningful risk. A smaller subgroup deserves a more careful conversation with their prescriber before starting.

Pre-Existing Chronic Kidney Disease

Men with an eGFR already below 60 mL/min/1.73m2 (CKD stage 3 or worse) have less renal reserve. In that population, any creatinine elevation from exogenous creatine is harder to interpret and may require more frequent lab monitoring. The 2022 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend against creatinine-only eGFR assessment in patients with conditions that alter creatinine production, which includes regular creatine supplementation (KDIGO, Kidney Int Suppl, 2022). Men in this category should use cystatin C-based monitoring as a standard practice.

Elevated Hematocrit at Baseline

If your hematocrit is already in the upper-normal range before starting Jatenzo (above 48 to 50 percent), adding an aggressive resistance training protocol supported by creatine will amplify the training stimulus and could accelerate the testosterone-driven rise in red cell mass. This is a reason to monitor hematocrit more frequently, not a reason to avoid creatine outright.

Polypharmacy and Anticoagulation

Jatenzo's label identifies anticoagulants, particularly warfarin, as an interaction requiring INR monitoring because testosterone can increase anticoagulant effect. Creatine does not affect clotting factors or warfarin pharmacokinetics based on available data, but men on warfarin who start creatine should have their INR rechecked within two weeks, simply because any change in diet, supplement stack, or training volume can shift INR indirectly through changes in vitamin K intake or liver metabolism.

What to Tell Your Prescriber

Disclosure is the entire management strategy here. The pharmacist at the dispensing pharmacy may flag creatine under a general "renal concern" category in drug-interaction software because the software cannot distinguish between creatinine as a pharmacologic effect and creatinine as a lab artifact. That flag does not mean the combination is dangerous.

Tell your prescriber:

• The brand, dose, and form of creatine you are taking (e.g., creatine monohydrate, 5 g per day)
• The date you started or plan to start
• Whether you are using a loading phase
• Your current training frequency and intensity

That four-point disclosure allows your physician to annotate your chart, order cystatin C if needed, and interpret future creatinine values correctly. The International Society of Sports Nutrition notes in its 2017 position paper that "creatine supplementation at doses of 3 to 5 g/day does not adversely affect kidney function in healthy, physically active individuals," a statement that should be shared with any clinician who expresses concern based solely on a mild creatinine elevation (Kreider et al., J Int Soc Sports Nutr, 2017).

Key Takeaways for Men on Jatenzo Considering Creatine

No pharmacokinetic interaction exists between oral testosterone undecanoate and creatine monohydrate. The only clinically meaningful issue is that creatine raises serum creatinine by 10 to 30 percent through a non-pathological mechanism, which can produce false-alarm lab results in the context of Jatenzo's required renal and hematologic monitoring schedule.

The practical solution is straightforward: disclose creatine use to your prescriber before labs are drawn, use a maintenance dose of 3 to 5 g per day rather than a loading phase if labs are scheduled within the next three weeks, and request cystatin C-based eGFR as part of your monitoring panel if you plan to take creatine long-term. Your target total testosterone on Jatenzo is 400 to 700 ng/dL, drawn 4 to 6 hours after the morning dose, and that target is unaffected by creatine at any dose studied in the literature.